...
首页> 外文期刊>Arquivos brasileiros de cardiologia. >Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures
【24h】

Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures

机译:华法林或达比加群抗凝治疗后牙科患者的出血强度评估

获取原文
           

摘要

Background:Thrombotic disorders remain one of the leading causes of death in the Western world. Dabigatran appeared as an alternative to warfarin for anticoagulation in the treatment of atrial fibrillation (AF). The risk associated with bleeding due to its use has been documented in several randomized clinical trials, but no large study has examined in detail the risk of bleeding during dental extraction and other dental procedures involving bleeding. Objective: To compare the intensity of bleeding in individuals taking dabigatran or vitamin K antagonist (warfarin) and undergoing dental procedures. Methods: Prospective, single-center, controlled study with one single observer. Patients diagnosed with nonvalvular AF, on warfarin or dabigatran, cared for at a cardiology referral center, and requiring single or multiple dental extractions, were evaluated up to seven days post-extraction. The following outcomes were assessed: bleeding time between the beginning and the end of suture and complete hemostasis; bleeding before the procedure, after 24 hours, 48 hours, 7 days, during and after suture removal (late); p<0.05 was defined as of statistical relevance. Results: We evaluated 37 individuals, 25 in the warfarin group and 12 in the dabigatran group. Age, sex, weight, height, blood pressure, color, schooling, family income and comorbidities were similar between the two groups. Regarding bleeding after 24 hours of the procedure, no one in the dabigatran group had bleeding, whereas 32% in the warfarin group had documented bleeding (p = 0.028). The other variables analyzed did not differ between the groups. Conclusions: This study suggests that, regarding dental extraction, there is no statistically significant difference in the intensity of bleeding of patients taking dabigatran as compared to those taking warfarin. Bleeding 24 hours after the procedure was less frequent among patients on dabigatran.
机译:背景:血栓形成性疾病仍然是西方世界主要的死亡原因之一。达比加群在房颤(AF)的治疗中似乎是华法林的替代抗凝剂。在数项随机临床试验中已记录了因使用止血药引起的出血风险,但尚无大型研究详细检查过拔牙和其他涉及出血的牙科手术过程中发生出血的风险。目的:比较服用达比加群或维生素K拮抗剂(华法林)并接受牙科手术的个体的出血强度。方法:由一名观察员进行的前瞻性,单中心,对照研究。对华法林或达比加群诊断为非瓣膜性房颤的患者,在心脏转诊中心进行护理,需要单次或多次拔牙,在拔牙后最多7天进行评估。评估了以下结果:缝合开始和结束之间的出血时间以及完全止血;手术前,手术后24小时,48小时,7天,缝合后和缝合后出血(后期);将p <0.05定义为具有统计相关性。结果:我们评估了37个人,华法林组为25个人,达比加群组为12个人。两组之间的年龄,性别,体重,身高,血压,肤色,学历,家庭收入和合并症相似。关于手术24小时后的出血,达比加群组中没有人有出血,而华法林组中有32%的人有出血(p = 0.028)。两组之间分析的其他变量没有差异。结论:这项研究表明,就拔牙而言,服用达比加群的患者的出血强度与服用华法林的患者在出血强度上无统计学差异。接受达比加群治疗的患者术后24小时出血较少。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号